Oral miltefosine in post‐kala‐azar dermal leishmaniasis – experience in three cases
Explore this paper's citation graph
Summary
Oral miltefosine has shown good efficacy in both VL and PKDL and there is need for an orally administered, safe and effective agent that can produce high cure rates within short periods.
- Type
- article
- Published
- 2010-05-01
- Cited by
- 12
- References
- 18
- OpenAlex
- https://openalex.org/W1953870686
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:9296026
Keywords
Miltefosine, Medicine, Leishmaniasis, Dermatology, Visceral leishmaniasis
References
- Drug Resistance in Leishmaniasis
- Efficacy of liposomal amphotericin B (AmBisome®) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL)
- Oral miltefosine for Indian visceral leishmaniasis.
- Combination of sodium stibogluconate and rifampicin in post kala-azar dermal leishmaniasis.
- Trial of oral miltefosine for visceral leishmaniasis.
- Oral miltefosine in the treatment of post‐kala‐azar dermal leishmaniasis
- Treatment of leishmaniasis with miltefosine: 2008 status
- Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses
- Successful miltefosine treatment of post-kala-azar dermal leishmaniasis occurring during antiretroviral therapy.
- Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post kala-azar dermal leishmaniasis.
- Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.
- Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment.
- Efficacy of ketoconazole in post-kala-azar dermal leishmaniasis.
- Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India.
- Post-Kala-Azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine.
- Alteration of Fatty Acid and Sterol Metabolism in Miltefosine-Resistant Leishmania donovani Promastigotes and Consequences for Drug-Membrane Interactions
- Chemotherapy of leishmaniasis: past, present and future.
- Allopurinol therapy in post-kala-azar dermal leishmaniasis.
Cited by
- Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.
- Miltefosine as an effective choice in the treatment of post‐kala‐azar dermal leishmaniasis
- Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters
- Challenges for management of post kala-azar dermal leishmaniasis and future directions
- Clinical pharmacology in leishmaniasis: treatment optimization of a neglected disease
- Miltefosine: a review of its pharmacology and therapeutic efficacy Miltefosine: a review of its pharmacology and therapeutic efficacy
- Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India
- Progress in antileishmanial drugs: Mechanisms, challenges, and prospects
- Study on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniasis: an open clinical trial and case–control study protocol
- UvA-DARE ( Digital Academic Repository ) Clinical pharmacology in leishmaniasis : treatment optimization of a neglected disease
- Leishmaniasis: An Update on a Neglected Tropical Disease
- Correction: Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India
- Clinical pharmacology in leishmaniasis: treatment optimization of a neglected disease
Related papers
- Relapse of visceral leishmaniasis after miltefosine treatment in a Nepalese patient.
- Portal hypertension as an independent manifestation of visceral leishmaniasis
- Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis.
- Oral miltefosine treatment in children with visceral leishmaniasis: a brief review.
- Post-Kala-Azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine.
- Development of Post–Kala-Azar Dermal Leishmaniasis (PKDL) in Miltefosine-Treated Visceral Leishmaniasis
- A case report on Para-kala-azar dermal leishmaniasis: an unresolved mystery
- Diagnosis of post kala azar dermal leishmaniasis in nonendemic Areas: A clinical challenge
- Leishmaniasis
- Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India.